𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subthalamic nucleus deep brain stimulation for Parkinson’s disease: 8 years of follow-up

✍ Scribed by Dianyou Li, Chunyan Cao, Jing Zhang, Shikun Zhan…

Book ID
120797516
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
148 KB
Volume
2
Category
Article
ISSN
2047-9158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two-year follow-up of subthalamic deep b
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease
✍ Jan Herzog; Jens Volkmann; Paul Krack; Florian Kopper; Monika Pötter; Delia Lore 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract We studied 48 patients after bilateral subthalamic nucleus deep brain stimulation (STN‐DBS) who were evaluated 6 months after the surgical procedure using the Unified Parkinson's Disease Rating Scale (UPDRS) in a standardized levodopa test. Additional follow‐up was available in 32 patie

Treatment of dysarthria following subtha
Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease
✍ Elina Tripoliti; Laura Strong; Freya Hickey; Tom Foltynie; Ludvic Zrinzo; Joseph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

## Abstract ## Background: Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an established treatment for patients with Parkinson's disease (PD). Speech impairment is a frequent side effect of the surgery. This study examined the efficacy of an intensive speech treatment, the Lee Silv

Beyond nine years of continuous subthala
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease
✍ Maurizio Zibetti; Aristide Merola; Laura Rizzi; Valeria Ricchi; Serena Angrisano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 1 views

## Abstract Deep brain stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson's disease. The benefits of bilateral subthalamic stimulation are well documented, and some studies reported outcomes with a follow‐up of 5 to 6 years; nevertheless, few data are available